US government reduces pediatric HIV treatment and testing under new global health strategy
Updated
Updated · The Guardian · Apr 26
US government reduces pediatric HIV treatment and testing under new global health strategy
9 articles · Updated · The Guardian · Apr 26
Recent data show pediatric HIV treatment fell from 643,627 in 2022 to 508,703 in 2025, while testing dropped from 1.7 million to 1.1 million, following the shift away from Pepfar.
Experts warn that rapid transition to bilateral partnerships and dismantling of oversight structures risk undermining HIV prevention, especially as infant testing and workforce capacity also decline sharply.
Concerns grow that reduced data transparency and potential resource-driven policies may jeopardize global HIV progress, with layoffs at key agencies and exclusion of major NGOs further complicating effective response.
As US support for 20 million HIV patients changes, who will fill the gap?
Could the new US strategy lead to 4.2 million preventable AIDS-related deaths?
With Pepfar's data systems gone, is the world flying blind against HIV?
How will linking HIV aid to mineral rights reshape global health security?
Can local health systems survive the abrupt withdrawal of US support and expertise?
Why are some African nations reportedly rejecting new US health partnership deals?